Quick Contact : 408-458-8343
Select Page
FacebookGoogle BookmarksTwitterLinkedInPinterestEmail

The objective of the adverse event reporting and subsequent evaluations is to improve protection of the health and safety of patients, users and others by disseminating information which may reduce the likelihood of, or prevent repetition of adverse events, or alleviate consequences of such repetition. This document has been created by the Global Harmonization Task Force Study Group 2: Medical Device Vigilance/Post Market Surveillance. Study Group 2 is made up of representatives of the regulatory authorities and industry representatives of the USA, Europe, Canada, Japan and Australia.

Please fill the form below to access the resource.







    By submitting this form you agree that we store and process your personal data as per our Privacy Policy. We will never sell your personal information to any third party.

    Webinars
    x
    Upcoming
    FDA’s Response to COVID-19: Fundamentals of Obtaining Emergency Use Authorizations

    Register

       January 27, 2021   |   01:30 - 02.15 PM EST

    Follow Us